Issue of Equity

14th Jan 2008 10:17

Akers Biosciences, Inc.14 January 2008 14 January 2008 Akers Biosciences, Inc. (the "Company") Issue of Equity The Company announces that it has issued 1,171,060 common shares of nil parvalue each ("Shares") in the Company to satisfy payment in respect of apromissory note due 22 November 2007. Application has therefore been made to theLondon Stock Exchange for the Shares to be admitted to trading on AIM, which isexpected to take place on 18 January 2008. Following admission, the Company will have 68,055,164 voting ordinary shares inissue. Contact:Thomas A. Nicolette +1 856 848 8698President Alasdair Younie/Phillip Young 020 7012 2000Arbuthnot Securities Limited This information is provided by RNS The company news service from the London Stock Exchange

---

Related Shares:

AKR.L